"Our goal at VoxelSensors is to seamlessly integrate the physical and digital worlds to a point level where they become indistinguishable."
"Our goal at VoxelSensors is to seamlessly integrate the physical and digital worlds to a point level where they become indistinguishable."
"Our goal at VoxelSensors is to seamlessly integrate the physical and digital worlds to a point level where they become indistinguishable."
Tanai Therapeutics is developing a first-in-class oral therapeutic for obesity.
"When it comes to battery-powered low energy sensing, Aloxy should be the go-to company for the petrochemical industry worldwide."
"When it comes to battery-powered low energy sensing, Aloxy should be the go-to company for the petrochemical industry worldwide."
"When it comes to battery-powered low energy sensing, Aloxy should be the go-to company for the petrochemical industry worldwide."
MRM Health is developing a novel type of therapeutics based on beneficial intestinal bacteria.
"The aim is to have one of the most prominent photonics hubs in Europe, and even globally, located in Ghent."
"The aim is to have one of the most prominent photonics hubs in Europe, and even globally, located in Ghent."
"The aim is to have one of the most prominent photonics hubs in Europe, and even globally, located in Ghent."
Flindr aims to restore a patient’s impaired immune response to cancer
Animab develops antibodies to tackle gastrointestinal pathogens in livestock.
"Swave’s HXR gigapixel technology will forever change the way we see and experience displayed still images, videos and live imaging."
"Swave’s HXR gigapixel technology will forever change the way we see and experience displayed still images, videos and live imaging."
"Swave’s HXR gigapixel technology will forever change the way we see and experience displayed still images, videos and live imaging."
Swave develops holographic eXtended reality technology to make virtual reality practically indistinguishable from the real world.
"Swave’s HXR gigapixel technology will forever change the way we see and experience displayed still images, videos and live imaging."
"Our technology has the potential to enhance the therapeutic effectiveness of cell-based therapies and make them more affordable.”
"Our technology has the potential to enhance the therapeutic effectiveness of cell-based therapies and make them more affordable.”
"Our technology has the potential to enhance the therapeutic effectiveness of cell-based therapies and make them more affordable.”
Blue Foot provides water-intensive industries with the technology to reuse water.
AmphiStar offers a portfolio of locally sourced biosurfactants to companies seeking to develop sustainable, performant & affordable products
Qbic fund is a seed and early-stage venture capital fund, supporting spin-offs or start-ups that valorize research from Qbic's knowledge partners.
A knowledge partner spin-off, i.e. a company that was founded based on technological innovations originating at Qbic's partner universities, research institutes or hospitals.
A start-up linked to a knowledge partner, i.e. a company with a strong R&D collaboration with one of Qbic's knowledge partners. This collaboration can be structured through joint development contracts, clinical studies, IP license agreements, etc.
